Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is one of the most lethal subtypes of breast cancer (BC), and it accounts for approximately 10%–20% of all invasive BCs diagnosed worldwide. The survival rate of TNBC in stages III and IV is very low, and a large number of patients are diagnosed in these stages....
Príomhchruthaitheoirí: | Md Shahin Alam, Adiba Sultana, Guanghui Wang, Md Nurul Haque Mollah |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Frontiers Media S.A.
2022-12-01
|
Sraith: | Frontiers in Molecular Biosciences |
Ábhair: | |
Rochtain ar líne: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.1049741/full |
Míreanna comhchosúla
Míreanna comhchosúla
-
Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis
de réir: Li L, et al.
Foilsithe / Cruthaithe: (2021-03-01) -
Discovery of Bacterial Key Genes from 16S rRNA-Seq Profiles That Are Associated with the Complications of SARS-CoV-2 Infections and Provide Therapeutic Indications
de réir: Md. Kaderi Kibria, et al.
Foilsithe / Cruthaithe: (2024-03-01) -
Discovery of key molecular signatures for diagnosis and therapies of glioblastoma by combining supervised and unsupervised learning approaches
de réir: Arnob Sarker, et al.
Foilsithe / Cruthaithe: (2024-11-01) -
Molecular characterisation of cell line models for triple-negative breast cancers
de réir: Grigoriadis Anita, et al.
Foilsithe / Cruthaithe: (2012-11-01) -
Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents
de réir: Md Abu Horaira, et al.
Foilsithe / Cruthaithe: (2023-03-01)